Please login to the form below

Not currently logged in
Email:
Password:

Baxalta

This page shows the latest Baxalta news and features for those working in and with pharma, biotech and healthcare.

Immunology keeps Shire figures solid as Takeda takeover nears

Immunology keeps Shire figures solid as Takeda takeover nears

$612m but the company’s haematology franchise – including haemophilia products acquired along with Baxalta in 2016 – down 1% to $951m.

Latest news

More from news
Approximately 16 fully matching, plus 33 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    quite as fast as Shire's move to take over Baxalta when it was spun out of Baxter in July 2015).

  • The good, the bad and the ugly The good, the bad and the ugly

    Shire’s incredible revenue growth of almost 57%, helped by its $32bn acquisition of Baxalta in 2016, lifted it into the top 20 for the first time in its history. ... However, investors fear that challenges in the $11bn haemophilia market could lead to

  • Accelerating innovation Accelerating innovation

    Going global. The company’s ambitions in cancer were boosted by last year’s appointment of new CEO David Meek, who joined the firm from Baxalta where he headed up that

  • Deal Watch January 2017 Deal Watch January 2017

    Interestingly 2016 had opened with Shire's announcement that the Baxalta acquisition was going ahead resulting in one of the year's biggest headlines with its final value of £32bn.

  • A rare talent A rare talent

    The biggest of these moves was its $32bn acquisition of Baxalta, which was officially completed in June last year and elevated its position in orphan drugs, which it expects to account ... The combination of Shire and Baxalta was extremely transformative,

More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Bedrock Healthcare Communications

    Abbvie. Baxalta. Baxter. Biogen. BMS. Britannia. CareFusion. Celgene. Ipsen. Janssen. Novartis.

  • FCB Halesway

    Abbott Vascular. Cardiovascular. Endovascular. Structural Heart. Baxalta. Haemophilia. Immunodeficiency. Bayer. Radiology solutions.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics